We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
-0.37%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.35B
AUM Growth
-$15.1M
Cap. Flow
+$10.3M
Cap. Flow %
0.76%
Top 10 Hldgs %
47.36%
Holding
392
New
45
Increased
215
Reduced
85
Closed
23

Sector Composition

Rank Sector Weight
1 Communication Services 9.8%
2 Technology 7.13%
3 Financials 2.52%
4 Healthcare 2.27%
5 Consumer Discretionary 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRAB icon
351
Grab
GRAB
$14.8B
$157K 0.01%
34,603
+3,407
+11% +$15.9K
CIO
352
DELISTED
City Office REIT
CIO
$147K 0.01%
28,354
+1,870
+7% +$9.6K
INGN icon
353
Inogen
INGN
$173M
$143K 0.01%
20,111
STLA icon
354
Stellantis
STLA
$16.7B
$139K 0.01%
12,428
-9,438
-43% -$121K
HAFN icon
355
Hafnia
HAFN
$3.66B
$107K 0.01%
25,622
+5,530
+28% +$27.4K
ICL icon
356
ICL Group
ICL
$6.45B
$104K 0.01%
18,531
+2,076
+13% +$12.2K
NVDA icon
357
PUT
NVIDIA
NVDA
$4.92T
$90.1K 0.01%
80,000
QSI icon
358
Quantum-Si Incorporated
QSI
$178M
$73.1K 0.01%
60,950
+50,150
+464% +$96.1K
DYAI icon
359
Dyadic International
DYAI
$44.1M
$68.5K 0.01%
50,759
+23,585
+87% +$35.5K
COTY icon
360
Coty
COTY
$2.38B
$56.3K ﹤0.01%
+10,288
New +$64.4K
CNTB
361
Connect Biopharma Holdings
CNTB
$139M
$44K ﹤0.01%
80,000
EQ icon
362
Equillium
EQ
$156M
$39.1K ﹤0.01%
99,688
IBRX icon
363
ImmunityBio
IBRX
$7.86B
$36.3K ﹤0.01%
12,055
GOSS icon
364
CALL
Gossamer Bio
GOSS
$68.9M
$31.5K ﹤0.01%
30,000
+10,000
+50% +$11.6K
ALLO icon
365
Allogene Therapeutics
ALLO
$611M
$30.8K ﹤0.01%
21,089
QSI icon
366
CALL
Quantum-Si Incorporated
QSI
$178M
$9K ﹤0.01%
40,000
-6,000
-13% -$11.5K
DIA icon
367
CALL
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.7B
$6.2K ﹤0.01%
+10,000
New +$4.32M
OPI
368
DELISTED
Office Properties Income Trust
OPI
$5.02K ﹤0.01%
+11,000
New +$9.39K
MRVI icon
369
CALL
Maravai LifeSciences
MRVI
$1.03B
$2K ﹤0.01%
14,000
ARW icon
370
Arrow Electronics
ARW
$10.5B
-2,296
Closed -$260K
BNS icon
371
Scotiabank
BNS
$107B
-4,058
Closed -$218K
CHRD icon
372
Chord Energy
CHRD
$7.25B
-1,809
Closed -$212K
CNI icon
373
Canadian National Railway
CNI
$76.9B
-2,104
Closed -$214K
DHR icon
374
Danaher
DHR
$142B
-1,360
Closed -$312K
EA icon
375
Electronic Arts
EA
$52.5B
-1,421
Closed -$208K

Similar funds

Callan Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Callan Capital held 392 positions worth $1.35B, down 1.1% from $1.37B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Callan Capital's Q1 2025 filing shows 45 new, 215 increased, 85 reduced and 23 closed positions. Its largest new stake was Primo Brands: 145,607 shares worth $5.17M. The largest sale was Meta Platforms (Facebook), an estimated $23M.

By sector, the portfolio is most concentrated in Communication Services at 9.8% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

  • Callan Capital's largest Q1 2025 buy was Primo Brands: 145,607 shares worth $5.17M.
  • Callan Capital added most to Schwab Fundamental US Small Company Index ETF in Q1 2025, an estimated $4.7M increase.
  • Callan Capital's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $23M.
  • Callan Capital fully exited Xtrackers Artificial Intelligence and Big Data ETF in Q1 2025, selling an estimated $333K.
  • Callan Capital's ten largest holdings make up 47% of its $1.35B portfolio in Q1 2025.
  • Callan Capital opened 45 new positions and closed 23 in Q1 2025.
  • Callan Capital's portfolio value fell 1.1% quarter-over-quarter to $1.35B.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.